Sms Pharmaceuticals (SMSPHARMA) | Stock Overview & Key Data
Sms Pharmaceuticals Performance Comparison
Stock Range
Today's Range
Low: ₹218.61
High: ₹234.00
on August 11, 2025
52 Week Range
Low: ₹176.05
High: ₹398.00
on March 3, 2025
on September 23, 2024
All-Time High: ₹398.00 on September 23, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR19.9B
EPS
8.16
P/E Ratio (TTM)
27.49
Forward P/E
N/A
P/B Ratio
3.11
PEG Ratio
N/A
Div. Yield
0.16%
ROE
11.76%
Beta
0.555
Debt to Equity
48.58
Financial Highlights
Profitability
Gross Margin
30.17%
Operating Margin
12.96%
Profit Margin
8.83%
Returns and Earnings
Return on Assets (TTM)
5.98%
Return on Equity (TTM)
11.76%
EBITDA
INR1.5B
Net Income (TTM)
INR691.4M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR88.29
Quarterly Revenue Growth (YoY)
1.00%
Quarterly Earnings Growth (YoY)
17.60%
Dividend Information
Last 12-Month Dividend
₹0.40
Current Dividend Yield
0.16%
3-Year Average Dividend Yield
0.23%
3-Year Average Annual Dividend
₹0.33
3-Year Total Dividends
₹1.00
Ex-Dividend Date
September 23, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Sms Pharmaceuticals SMSPHARMA | 19.89B Small-cap | -2.01% | -6.63% | -7.22% | 6.32% | -12.61% | -20.98% | 157.68% | 136.24% |
| GlaxoSmithKline GLAXO | 455.21B Large-cap | -9.72% | -18.70% | -3.36% | 23.80% | 18.77% | -7.37% | 83.73% | 74.63% |
| Pfizer PFIZER | 229.65B Large-cap | -1.22% | -14.66% | 17.12% | 17.53% | -5.92% | -14.67% | 18.26% | 11.33% |
| Senores SENORES | 30.05B Small-cap | -1.95% | 10.42% | 34.86% | 18.36% | 14.20% | 13.83% | 13.83% | 13.83% |
| TTK Healthcare TTKHLTCARE | 16.13B Small-cap | -9.25% | -12.37% | -2.49% | -8.81% | -18.76% | -28.03% | 38.64% | 124.19% |
| Kopran KOPRAN | 7.57B Small-cap | -1.23% | -12.23% | -12.38% | -11.92% | -26.13% | -40.51% | -15.25% | 143.79% |
Ownership & Short Interest
Insider Ownership
73.63%
Institutional Ownership
2.43%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
66K
Average 90-Day Volume
81K
Sms Pharmaceuticals Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Sms Pharmaceuticals would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is SMSPHARMA's 52-week high and low?
- In the last 52 weeks, Sms Pharmaceuticals reached a high of ₹398.00 (on September 23, 2024) and a low of ₹176.05 (on March 3, 2025).
- What is the market cap and P/E ratio for SMSPHARMA?
- Curious about Sms Pharmaceuticals's size and valuation? Its market capitalization stands at 19.89B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.49, and the forward P/E (looking ahead) is N/A.
- Does SMSPHARMA pay dividends? If so, what's the yield?
- Yes, Sms Pharmaceuticals is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.16%, and the company has paid an average of ₹0.33 per share annually over the past 3 years.
- Who are Sms Pharmaceuticals's main competitors or similar companies to consider before investing?
When looking at Sms Pharmaceuticals, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return GlaxoSmithKline
GLAXO455.21B Healthcare Drug Manufacturers - General -7.37% 83.73% Pfizer
PFIZER229.65B Healthcare Drug Manufacturers - General -14.67% 18.26% Senores
SENORES30.05B Healthcare Drug Manufacturers - General 13.83% 13.83% TTK Healthcare
TTKHLTCARE16.13B Healthcare Drug Manufacturers - General -28.03% 38.64% Kopran
KOPRAN7.57B Healthcare Drug Manufacturers - General -40.51% -15.25% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Sms Pharmaceuticals Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Sms Pharmaceuticals's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.76%, the Debt to Equity ratio from the most recent quarter is 48.58, and its Gross Profit Margin stands at 30.17%.
- What is the recent revenue and earnings growth for SMSPHARMA?
- Looking at Sms Pharmaceuticals's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 1.00%, and quarterly earnings saw a YoY growth of 17.60%.
- How much of SMSPHARMA stock is held by insiders and institutions?
- Wondering who owns Sms Pharmaceuticals stock? Company insiders (like executives and directors) hold about 73.63% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.43%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.